A noncanonical AR addiction drives enzalutamide resistance in prostate cancer
Yundong He(Mayo Clinic), Haojie Huang(Mayo Clinic)
Cited by 89
Related Papers
FOXO1 Inhibits Runx2 Transcriptional Activity and Prostate Cancer Cell Migration and Invasion
|Cancer Research|2011|163
BRCA1 is a negative modulator of the PRC2 complex
|The EMBO Journal|2013|114
FOXA1 overexpression suppresses interferon signaling and immune response in cancer
|Journal of Clinical Investigation|2021|87
A Transcription-Independent Function of FOXO1 in Inhibition of Androgen-Independent Activation of the Androgen Receptor in Prostate Cancer Cells
|Cancer Research|2008|65
Dual inhibition of AKT‐mTOR and AR signaling by targeting HDAC3 in PTEN‐ or SPOP‐mutated prostate cancer
|EMBO Molecular Medicine|2018|51